MetaADEDB: ADE

MetaADEDB 2.0 @ LMMD

Cystadenoma

(UMLS:C0010633)

Definition:: A benign neoplasm derived from glandular epithelium, in which cystic accumulations of retained secretions are formed. In some instances, considerable portions of the neoplasm, or even the entire mass, may be cystic. (Stedman, 25th ed)
UMLS ID:: C0010633
MeSH ID:: D003537

Classification:

Name:

Neoplasms
MeSH Tree Number(s):: C04.557.470.035.320|C04.557.470.590.485

Synonym(s)

Cystadenoma

CYSTADENOMA

CYSTADENOMA, BENIGN

Cystadenoma NOS

Cystadenoma, NOS

Cystoma

Cystoma, NOS

[M]Cystadenoma NOS

cystadenoma

10.

cystadenomas

11.

cystoma

Associated Drug(s)

	Name	Reference(s)	Data Source
1	Diethylnitrosamine	3702427	CTD
2	Diethylstilbestrol	165277	CTD
3	Nandrolone Decanoate	3702427	CTD
4	bisphenol A	19590677	CTD

Similar ADE(s)

	Name	Semantic Similarity
1	Mesothelioma	58.1%
2	Cystadenocarcinoma	52.2%
3	Mucoepidermoid Carcinoma	52.2%
4	Pseudomyxoma Peritonei	47.3%
5	Adenomatosis, Pulmonary	47.3%
6	Adenomatous Polyps	47.3%
7	Carcinoma	45.7%
8	Epithelioma	45.7%
9	Basal cell carcinoma	45.2%
10	Carcinoma, Papillary	45.2%
11	Squamous cell carcinoma	45.2%
12	Carcinoma, Basal Cell	45.2%
13	Neoplasms, Neuroepithelial	42.9%
14	Gliomatosis cerebri	42.9%
15	Adenoma, Acidophil	39.7%
16	Bowen's Disease	33.6%
17	leukemia	33.3%
18	Neoplasms, Germ Cell and Embryonal	33.3%
19	Germ Cell Cancer	33.3%
20	Carcinoma, Ehrlich Tumor	31.4%
21	Carcinoma, Lewis Lung	31.4%
22	Adenocarcinoma	30.1%
23	Carcinoma in Situ	30.1%
24	Carcinoma, Transitional Cell	30.1%
25	Papilloma	30.1%
26	Papillomatosis	30.1%
27	Carcinoma, Large Cell	30.1%
28	Carcinoma, Small Cell	30.1%
29	Carcinoma, Lobular	29.6%
30	Neuroectodermal Tumors	29.5%
31	Ganglioneuroma	29.5%
32	Glioma	29.5%
33	Malignant Glioma	29.5%
34	Medulloblastoma	28.6%
35	Adenofibroma	28.5%
36	Fibroadenoma	28.5%
37	Acanthoma	27.6%
38	Hepatocellular Adenoma	26.1%
39	Histiocytic Disorders, Malignant	25%
40	Carcinoid Tumor	24.9%
41	Carcinosarcoma	24.4%
42	Hemangiosarcoma	24.4%
43	lymphangiosarcoma	24.4%
44	melanoma	23.2%
45	Astrocytoma	22.9%
46	Ependymoma	22.9%
47	oligodendroglioma	22.9%
48	Ganglioglioma	22.9%
49	gliosarcoma	22.9%
50	Anaplastic astrocytoma	22.9%
51	Anaplastic Oligodendroglioma	22.9%
52	Adenoma	22.8%
53	Cystadenoma	22.6%
54	Adenoid Cystic Carcinoma	22.5%
55	Adenocarcinoma, Clear Cell	22.5%
56	Cholangiocarcinoma	22.5%
57	Cervical Intraepithelial Neoplasia	22.5%
58	Prolactinoma	22.2%
59	Growth Hormone-Secreting Pituitary Adenoma	22.2%
60	Meningioma	21.1%
61	Choriocarcinoma	21%
62	Hamartoma	20.9%
63	Neoplasms, Hormone-Dependent	20.9%
64	Neoplasms, Multiple Primary	20.9%
65	Paraneoplastic Syndromes	20.9%
66	Precancerous Conditions	20.9%
67	Neoplasms, Second Primary	20.9%
68	Malignant Carcinoid Syndrome	20.7%
69	Carcinoma 256, Walker	20.3%
70	Lymphoma	20%
71	Glioblastoma	19.7%
72	Neuroblastoma	19.7%
73	Glioblastoma Multiforme	19.7%
74	Ameloblastoma	19.6%
75	Angiokeratoma	19.6%
76	Chordoma	19.6%
77	Hemangioma	19.6%
78	hemangiopericytoma	19.6%
79	Lymphangioma	19.6%
80	Mesenchymoma	19.6%
81	Nevus	19.6%
82	Teratoma	19.6%
83	Hepatoblastoma	19.6%
84	Mixed Tumor, Mullerian	19.6%
85	Germinoma	19.6%
86	Teratocarcinoma	19.6%
87	Angiofibroma	19.6%
88	Composite Lymphoma	19.6%
89	Sarcoma	19.6%
90	Leukemia, Plasma Cell	19.5%
91	Chondrosarcoma	19.4%
92	Craniopharyngioma	19.4%
93	leiomyosarcoma	19.4%
94	liposarcoma	19.4%
95	synovial sarcoma	19.4%
96	Neuroectodermal Tumor, Melanotic	19.4%
97	Angiomyolipoma	19.4%
98	Clear Cell Sarcoma of Soft Tissue	19.4%
99	Alveolar Soft Part Sarcoma	19.4%
100	Neuroendocrine Tumors	19.4%
101	Sarcoma, Myeloid	19.4%
102	Trophoblastic Neoplasms	18.7%
103	Klatskin Tumor	18.7%
104	Leukemia, Experimental	18.5%
105	Dermoid Cyst	18.2%
106	Retinoblastoma	18.2%
107	Ganglioneuroblastoma	18.1%
108	Neurilemmoma	17.3%
109	Hutchinson's Melanotic Freckle	17.3%
110	Melanoma, Amelanotic	17.3%
111	Melanoma, Experimental	17.2%
112	Fibrosarcoma	16.9%
113	Osteosarcoma	16.9%
114	Carcinoma, Pancreatic Ductal	16.8%
115	Basal Cell Nevus Syndrome	16.3%
116	Cyst	15.8%
117	Neoplastic Processes	15.8%
118	Neoplastic Syndromes, Hereditary	15.8%
119	Pregnancy Complications, Neoplastic	15.8%
120	Carcinoid Heart Disease	15.8%
121	Leukemia, Radiation-Induced	15.6%
122	insulinoma	15.6%
123	Malignant Fibrous Histiocytoma	15.6%
124	Neoplasms, Experimental	15.5%
125	Plasmacytoma	14.8%
126	Malignant histiocytosis	14.6%
127	Leukemia L1210	14.6%
128	Leukemia P388	14.6%
129	Histiocytic sarcoma	14.6%
130	Sarcoma, Experimental	14.5%
131	Endometrial Stromal Sarcoma	14.4%
132	Paraganglioma	14.4%
133	Rhabdomyosarcoma	14.4%
134	Giant Cell Tumor of Bone	14.4%
135	Thymoma	14.4%
136	Adenomatous Polyposis Coli	13.4%
137	Dermatofibrosarcoma	13.2%
138	Dermatofibrosarcoma Protuberans	13.2%
139	Phyllodes Tumor	12.9%
140	Dysgerminoma	12.9%
141	Hemangioendothelioma	12.9%
142	Lipoma	12.9%
143	Myoma	12.9%
144	Myxoma	12.9%
145	Neuroma	12.9%
146	Seminoma	12.9%
147	Angiolipoma	12.9%
148	Myelolipoma	12.9%
149	Neoplasms, Bone Tissue	12.9%
150	Neoplasms, Fibrous Tissue	12.9%
151	Smooth Muscle Tumor	12.9%
152	Desmoplastic Small Round Cell Tumor	12.9%
153	Lymphangioleiomyomatosis	12.9%
154	Chondroma	12.9%
155	Enchondroma	12.9%
156	Carcinoma, Ovarian Epithelial	12.9%
157	Multiple Endocrine Neoplasia	12.6%
158	Neoplasms, Radiation-Induced	12.4%
159	Sarcoma 180	12.1%
160	Pheochromocytoma	12%
161	Alveolar rhabdomyosarcoma	12%
162	Hodgkin Disease	11.7%
163	Lymphoma, Non-Hodgkin	11.7%
164	Neurofibrosarcoma	11.6%
165	Abdominal Neoplasms	11.1%
166	Erythroplasia	11.1%
167	Follicular cyst	11.1%
168	Head and Neck Neoplasms	11.1%
169	Mucocele	11.1%
170	Pilonidal Cyst	11.1%
171	Soft Tissue Neoplasms	11.1%
172	Thoracic Neoplasms	11.1%
173	Thyroglossal Cyst	11.1%
174	Synovial Cyst	11.1%
175	Aberrant Crypt Foci	11.1%
176	Optic Nerve Glioma	11.1%
177	Vipoma	11%
178	Adrenocortical carcinoma	11%
179	Nasopharyngeal carcinoma	10.9%
180	Paraneoplastic Encephalomyelitis	10.8%
181	Mammary Neoplasms, Experimental	10.6%
182	Lymphomatoid Granulomatosis	10.3%
183	Nephroblastoma	10.1%
184	Primary amyloidosis	9.8%
185	Leukemia, Myelomonocytic, Chronic	9.7%
186	Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative	9.7%
187	fibroma	9.6%
188	Fibromatosis	9.6%
189	Osteoblastoma	9.6%
190	Osteoma	9.6%
191	Rhabdomyoma	9.6%
192	Chondromatosis	9.6%
193	Hemangioblastoma	9.6%
194	Lymphoma, Extranodal NK-T-Cell	9.6%
195	Renal Cell Carcinoma	9.6%
196	Papillary Renal Cell Carcinoma	9.6%
197	Gastrinoma	9.4%
198	Glucagonoma	9.4%
199	Carcinoma, Endometrioid	9.4%
200	Tuberous Sclerosis	9.2%
201	Digestive System Neoplasms	8.8%
202	Endocrine Gland Neoplasms	8.8%
203	Eye Neoplasms	8.8%
204	Nervous System Neoplasms	8.8%
205	Acoustic Neuroma	8.7%
206	Bone neoplasms	8.5%
207	Leukoplakia	8.5%
208	Lymphocele	8.5%
209	Pancreatic Cyst	8.5%
210	Skin Neoplasms	8.5%
211	Hematologic Neoplasms	8.5%
212	Mesoblastic Nephroma	8.5%
213	Barrett Esophagus	8.3%
214	Breast Cyst	8.3%
215	Hydatidiform Mole	8.3%
216	Actinic keratosis	8.3%
217	Mediastinal Cyst	8.3%
218	Neoplasm Invasiveness	8.3%
219	Neoplasm Metastasis	8.3%
220	Neoplasm Recurrence, Local	8.3%
221	Parovarian Cyst	8.3%
222	Pericardial Cyst	8.3%
223	Splenic Neoplasms	8.3%
224	Thymic Cyst	8.3%
225	Carcinogenesis	8.3%
226	Myxoid cyst	8.3%
227	Metastasis	8.3%
228	Fibromatosis, Aggressive	8%
229	Fibromatosis, Abdominal	8%
230	Mastocytosis	7.9%
231	Sturge-Weber Syndrome	7.9%
232	Gastrointestinal Stromal Tumors	7.8%
233	Hemangioma, Cavernous	7.8%
234	Leukemia, T-Cell	7.7%
235	Leukemia, B-Cell	7.7%
236	neurofibroma	7.7%
237	Lymphoma, Follicular	7.7%
238	T-Cell Lymphoma	7.7%
239	Mantle cell lymphoma	7.7%
240	Multiple Endocrine Neoplasia Type 1	7.5%
241	Waldenstrom Macroglobulinemia	7.4%
242	Multiple Myeloma	7.4%
243	Mastocytoma	7.3%
244	Mastocytosis, Systemic	7.2%
245	Leukemia, Myeloid, Chronic-Phase	7.2%
246	Parathyroid Neoplasms	6.7%
247	Peritoneal Neoplasms	6.7%
248	Thyroid Neoplasm	6.7%
249	Thyroid carcinoma	6.7%
250	Liver Neoplasms, Experimental	6.6%
251	Corpus Luteum Cyst	6.6%
252	Ovarian Cysts	6.6%
253	Retroperitoneal Neoplasms	6.5%
254	granulosa cell tumor	6.4%
255	Pancreatic Neoplasm	5.8%
256	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma	5.8%
257	Leukemia, Large Granular Lymphocytic	5.8%
258	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	5.8%
259	Lymphoma, T-Cell, Cutaneous	5.7%
260	Lymphoma, AIDS-Related	5.7%
261	Enteropathy-Associated T-Cell Lymphoma	5.7%
262	Primary Effusion Lymphoma	5.7%
263	Choledochal Cyst	5.6%
264	Tracheal Neoplasms	5.6%
265	Peutz-Jeghers Syndrome	5.5%
266	Leukoplakia, Oral	5.5%
267	Paraneoplastic Cerebellar Degeneration	5.4%
268	Leydig Cell Tumor	5.1%
269	Mouth Neoplasms	5%
270	Central Nervous System Neoplasms	5%
271	Vascular Neoplasms	5%
272	Thymus Neoplasms	5%
273	Dupuytren Contracture	4.9%
274	Genital Neoplasms, Female	4.9%
275	Pancreatic Pseudocyst	4.9%
276	Lymphatic Metastasis	4.9%
277	Neoplasms, Unknown Primary	4.9%
278	Leukemic Infiltration	4.9%
279	Breast Neoplasms, Male	4.9%
280	Neoplasm Micrometastasis	4.9%
281	Triple Negative Breast Neoplasms	4.9%
282	Urticaria Pigmentosa	4.8%
283	Mycosis Fungoides	4.8%
284	Lymphomatoid Papulosis	4.8%
285	Plasmablastic lymphoma	4.8%
286	Esophageal Neoplasms	4.7%
287	Denys-Drash Syndrome	4.7%
288	Limbic Encephalitis	4.7%
289	Thyroid Nodule	4.3%
290	Lambert-Eaton Myasthenic Syndrome	4.1%
291	Testicular Neoplasms	4.1%
292	Burkitt Lymphoma	4.1%
293	Adrenal Gland Neoplasms	4.1%
294	Gastrointestinal Neoplasms	4.1%
295	Genital Neoplasms, Male	4.1%
296	Liver neoplasms	4.1%
297	Uveal Neoplasms	4.1%
298	Urologic Neoplasms	4%
299	Sebaceous Gland Neoplasms	3.9%
300	Spinal Neoplasms	3.9%
301	Bone Marrow Neoplasms	3.9%
302	Polycystic Ovary Syndrome	3.9%
303	Opsoclonus-Myoclonus Syndrome	3.7%
304	Sezary Syndrome	3.4%
305	Xeroderma Pigmentosum	3.3%
306	Myelitis, Transverse	3.3%
307	Meningeal Neoplasms	3.3%
308	Nose Neoplasms	3%
309	Palatal Neoplasms	2.8%
310	ovarian neoplasm	2.8%
311	Pituitary Adenoma	2.7%
312	Pituitary Neoplasms	2.7%
313	Ear Neoplasms	2.7%
314	Eyelid Neoplasms	2.7%
315	Lung Neoplasms	2.7%
316	Pleural Neoplasms	2.7%
317	Cell Transformation, Viral	2.6%
318	Brain Neoplasms	2.6%
319	Salivary Gland Neoplasms	2.6%
320	Spinal Cord Neoplasms	2.6%
321	Tongue Neoplasms	2.6%
322	Uterine Neoplasms	2.6%
323	Vaginal Neoplasms	2.6%
324	Vulvar Neoplasms	2.6%
325	Uterine Cancer	2.6%
326	Fallopian Tube Neoplasms	2.6%
327	Meningeal Carcinomatosis	2.4%
328	Pharyngeal Neoplasms	2.3%
329	Central Nervous System Cysts	2.2%
330	Bile Duct Neoplasms	2.2%
331	gallbladder neoplasm	2.2%
332	Intestinal Neoplasms	2.2%
333	Penile Neoplasms	2.2%
334	Prostatic Neoplasms	2.2%
335	Stomach Neoplasms	2.2%
336	Zollinger-Ellison syndrome	2.2%
337	Polycythemia Vera	2.2%
338	Bronchial Neoplasms	2%
339	Multiple Pulmonary Nodules	2%
340	Laryngeal neoplasm	2%
341	Supratentorial Neoplasms	1.9%
342	Endometrial Neoplasms	1.9%
343	Bladder Neoplasm	1.9%
344	Kidney Neoplasm	1.9%
345	Ureteral Neoplasms	1.9%
346	Urethral Neoplasms	1.9%
347	Hypopharyngeal Neoplasms	1.6%
348	Pleural Effusion, Malignant	1.6%
349	Hypopharyngeal Cancer	1.6%
350	Parotid Neoplasms	1.6%
351	Prostatic Neoplasms, Castration-Resistant	1.6%
352	Nelson Syndrome	1.6%
353	Brain Stem Neoplasms	1.6%
354	Choroid Plexus Papilloma	1.4%
355	Cecal Neoplasms	1.4%
356	Duodenal Neoplasms	1.4%
357	Tonsillar Neoplasms	1.3%
358	Cerebellar Neoplasms	1.3%
359	Nasopharyngeal Neoplasms	1.2%
360	Colorectal Neoplasms	1.2%
361	Radicular Cyst	1.1%
362	Appendiceal Neoplasms	1.1%
363	Colonic Neoplasms	1.1%
364	Rectal Neoplasms	1.1%
365	Paranasal Sinus Neoplasms	1.1%
366	Maxillary Sinus Neoplasms	0.9%
367	Anus Neoplasms	0.9%
368	Sigmoid Neoplasms	0.9%

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234